Fairvalue-Calculator Fairvalue-Calculator
EN DE

Sensorion SA (ALSEN) Fair Value & Analysis

Healthcare · FR · Market cap €206M

Price€0.2480
Fair Value€0.3900
Upside+57.3%
Quality95/100
Evidence: Low Range €0.2900 – €0.4900

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Sensorion SA (ALSEN) currently trades at €0.2480, while our model-based Fair Value estimate is €0.3900 — implying the stock looks roughly 57.3% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Sensorion SA, a biotechnology company, engages in the development of novel therapies to restore, treat, and prevent hearing loss disorders in France. The company develops SENS-501, a dual AAV vector gene therapy development product for restoring hearing in patients with mutations in OTOF gene in Phase 1/2 clinical trials; and SENS-601, a candidate for the treatment of hearing loss caused by mutations of the GJB2 gene in preclinical studies. It is also developing SENS-40, a small molecule in Phase 2b clinical trials to treat sudden sensorineural hearing loss; prevention of residual hearing loss following cochlear implantation in Phase 2a clinical trials; and prevention of cisplatin-induced ototoxicity in Phase 2a clinical trials. The company was incorporated in 2009 and is headquartered in Montpellier, France.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -32% Regeneron Pharmaceuticals, Inc (REGN) -4% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +1% Alnylam Pharmaceuticals, Inc (ALNY) -82%

Frequently asked questions

Is Sensorion SA (ALSEN) undervalued?
As of Jun 24, 2026, our model estimates a fair value of €0.3900 versus a price of €0.2480 — about +57% (undervalued). Model-based estimate, not financial advice.
What is the fair value of ALSEN?
Our 21-model fair value for Sensorion SA is €0.3900 (as of Jun 24, 2026), built from audited fundamentals. The current price is €0.2480.
What is the quality score of ALSEN?
Sensorion SA has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.